Researchers at Charles Sturt University (CSU) are seeking participants aged 50 years or more for a study of the long-term side-effects of hormonal therapy on musculoskeletal structure and function in prostate cancer patients. Dr Jack Cannon, lecturer and researcher at the CSU School of Human Movement Studies at Bathurst, says, “Men who have received hormonal therapy for the treatment of prostate cancer are at significant long-term risk of osteoporosis, frailty, falling, and reduced functional ability. The results of this study of muscle strength, body composition, and bone mineral density will help to determine the long-term side-effects of hormonal therapy on musculoskeletal structure and function in such patients. This will assist in the development of interventions aimed to minimise long-term musculoskeletal risks and reduce secondary health conditions in these individuals. Testing will require only a single visit to our laboratory for about an hour, and anyone from the wider Central West region who has been treated for prostate cancer is invited to participate,” Dr Cannon said.